接受体外膜氧化器辅助高风险冠状动脉干预的患者的长期结果
Aiyuan Cheng1, Bo Wang1, Guotao Fu1
1Department of Cardiology, Xijing Hospital, Xi'an, China.
概括
对于无法接受冠状动脉旁路移植 (CABG) 的患者,可以进行高风险的穿皮冠状动脉干预 (PCI) 辅助静脉外膜氧化 (VA-ECMO). 经验丰富的操作人员在10个以上的病例中,可显著降低1年死亡风险.
科学领域:
- 心脏病学
- 干预心脏病学
- 心血管外科
背景情况:
- 对于接受静脉外膜氧化 (VA- ECMO) 辅助高风险穿皮冠状动脉干预 (PCI) 的患者,长期结果的数据有限.
- 运营商经验对这些结果的影响还不清楚.
研究的目的:
- 研究VA- ECMO辅助PCI患者的长期结果.
- 评估操作人员经验对患者结果的影响.
主要方法:
- 一项回顾性队列研究包括220名由于高手术风险而拒绝冠状动脉旁路移植 (CABG) 的患者,接受VA- ECMO辅助的PCI治疗.
- 主要终点是1岁时全因死亡.
- 经营者经验是根据执行超过10例VA- ECMO辅助的PCI进行分类的.
主要成果:
- 一年全因死亡率为25.5% (220名患者中56名).
- 经验丰富的操作人员治疗的患者 (超过10例) 与经验较少的操作人员治疗的患者相比,死亡风险降低了44%.
- 经验丰富的操作人员的经验门是执行10例VA-ECMO辅助的PCI.
结论:
- 对于不适合CABG的高风险患者,VA-ECMO辅助的PCI是一种可行的策略.
- 在VA-ECMO协助的PCI中,执行超过10个案例是将经验丰富的运营商归类为潜在的门.
相关概念视频
Cardiomyopathy VII: Pre and Post Operative Nursing Management
27
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
27
Cardiomyopathy V: Interprofessional Care
33
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Coronary Artery Disease V: Interprofessional Care
30
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30


